tiprankstipranks
Trending News
More News >

Memphasys Limited Appoints New Auditor Amidst Strategic Commercialization Efforts

Story Highlights
Memphasys Limited Appoints New Auditor Amidst Strategic Commercialization Efforts

Confident Investing Starts Here:

Memphasys Ltd ( (AU:MEM) ) has issued an announcement.

Memphasys Limited has announced a change in its external auditors, appointing BDO Audit Pty Ltd following the resignation of Pitcher Partners. This decision comes as part of a corporate review by the Board, aligning with the company’s strategic move towards the international commercialization of its Felix™ Device.

More about Memphasys Ltd

Memphasys Limited is a biotechnology company specializing in advanced reproductive biotechnology. They develop medical devices, diagnostics, and proprietary media for both human and animal applications. Their flagship technologies include the Felix™ and RoXsta™ Systems, aimed at enhancing fertility outcomes globally.

Average Trading Volume: 52,211,380

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$9.92M

See more data about MEM stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1